Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
4765-4 HLA-B55(22) PrThr Bld/Tiss Pt Ord     ACTIVE HLA-B55(22) [Presence]   MIN DefinitionDescription                   HLA   4765-4         Observation       0 HLA-B55(22) Ql           Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue 2.56 1                     This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
47650-7 Homogentisate/Creatinine SRto Urine Pt Qn     ACTIVE Homogentisate/Creatinine [Molar ratio] in Urine   MIN DefinitionDescription     umol/mmol creatinine             CHEM   47650-7         Both       0 Homogentisate/Creat Ur-sRto       N   Chemistry; CR; Crea; Creat; HGA; Homogen; Homogentisic acid; Homogentistic acid; Melanate; Melanic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn 2.7 2.21               umol/mmol{creat}       0
47651-5 Hydroxyproline SCnc Bld.dot Pt Qn     ACTIVE Hydroxyproline [Moles/volume] in DBS   MIN DefinitionDescription     umol/L             CHEM   47651-5         Both       0 OH-Proline DBS-sCnc       N   Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Hydroxylproline; Hydroxyprol; Hydroxy-proline; Hydrxprol; Hydrxproln; Hydrxyprln; Hyp; Level; Ohpro; OH-Proline; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood 2.7 2.21               umol/L       0
47652-3 Hypoxanthine phosphoribosyltransferase CCnt Placenta Pt Qn     ACTIVE Hypoxanthine phosphoribosyltransferase [Enzymatic activity/mass] in Placenta   MIN DefinitionDescription     nmol/min/mg protein             CHEM   47652-3         Both       0 HPRT Placenta-cCnt       N   Catalytic Content; Chemistry; HGPRT; HPRT; hypoxanthine-guanine phosphoribosyltransferase; Placent; Placental; Point in time; QNT; Quan; Quant; Quantitative; Random 2.7 2.21               nmol/min/mg{protein}     Changed System from Placent to Placenta so that all terms with a System of Placenta are consistent. 0
47653-1 Insulin^10M post dose glucagon ACnc Ser/Plas Pt Qn     ACTIVE Insulin [Units/volume] in Serum or Plasma --10 minutes post dose glucagon   MIN DefinitionDescription     mIU/mL;uIU/mL             CHAL   47653-1         Both       0 Insulin 10M p Gc SerPl-aCnc       N   10M p Gc; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; HGF; HUM; Humulin; Hyperglycemic factor; IH7; Insul; Lente; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente 2.7 2.21               u[IU]/mL       0
47654-9 Insulin^10M post dose glucose ACnc Ser/Plas Pt Qn     ACTIVE Insulin [Units/volume] in Serum or Plasma --10 minutes post dose glucose   MIN DefinitionDescription     mIU/mL;uIU/mL             CHAL   47654-9         Both       0 Insulin 10M p Glc SerPl-aCnc       N   10M p Glc; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; NPH; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente 2.7 2.21               u[IU]/mL       0
47655-6 Insulin^15M post dose glucagon ACnc Ser/Plas Pt Qn     ACTIVE Insulin [Units/volume] in Serum or Plasma --15 minutes post dose glucagon   MIN DefinitionDescription     mIU/mL;uIU/mL             CHAL   47655-6         Both       0 Insulin 15M p Gc SerPl-aCnc       N   15M p Gc; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; HGF; HUM; Humulin; Hyperglycemic factor; IH7; Insul; Lente; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente 2.7 2.21               u[IU]/mL       0
47656-4 Insulin^1M post dose glucose ACnc Ser/Plas Pt Qn     ACTIVE Insulin [Units/volume] in Serum or Plasma --1 minute post dose glucose   MIN DefinitionDescription     mIU/mL;uIU/mL             CHAL   47656-4         Both       0 Insulin 1M p Glc SerPl-aCnc       N   1M p Glc; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; NPH; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente 2.7 2.21               u[IU]/mL       0
47657-2 Insulin^1H post dose glucose ACnc Ser/Plas Pt Qn     ACTIVE Insulin [Units/volume] in Serum or Plasma --1 hour post dose glucose   MIN DefinitionDescription     mIU/mL;uIU/mL             CHAL   47657-2         Both       0 Insulin 1h p Glc SerPl-aCnc       N   1 hour; 1.0Hr; 1h p Glc; 60 min; 60 minutes; 60M; 60min; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; NPH; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente 2.73 2.21               u[IU]/mL       0
47658-0 Insulin^1.5H post dose glucose ACnc Ser/Plas Pt Qn     ACTIVE Insulin [Units/volume] in Serum or Plasma --1.5 hours post dose glucose   MIN DefinitionDescription     mIU/mL;uIU/mL             CHAL   47658-0         Both       0 Insulin 1.5h p Glc SerPl-aCnc       N   1 1/2 hours; 1 1/2 HR; 1.5h p Glc; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; NPH; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente 2.73 2.21               u[IU]/mL       0
47659-8 Insulin^2H post dose glucose ACnc Ser/Plas Pt Qn     ACTIVE Insulin [Units/volume] in Serum or Plasma --2 hours post dose glucose   MIN DefinitionDescription     mIU/mL;uIU/mL             CHAL   47659-8         Both       0 Insulin 2h p Glc SerPl-aCnc       N   120 min; 120 minutes; 120min; 2 hours; 2h p Glc; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; NPH; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente 2.73 2.21               u[IU]/mL       0
4766-2 HLA-B56(22) PrThr Bld/Tiss^Donor Pt Ord     ACTIVE HLA-B56(22) [Presence] in Donor   MAJ DefinitionDescription                   HLA   4766-2         Observation       0 HLA-B56(22) Donr Ql           Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue 2.56 1                     This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld^donor' to 'Bld/Tiss^donor' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
47660-6 Insulin^2.5H post dose glucose ACnc Ser/Plas Pt Qn     ACTIVE Insulin [Units/volume] in Serum or Plasma --2.5 hours post dose glucose   MIN DefinitionDescription     mIU/mL;uIU/mL             CHAL   47660-6         Both       0 Insulin 2.5h p Glc SerPl-aCnc       N   2.5h p Glc; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; NPH; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente 2.7 2.21               u[IU]/mL       0
47661-4 Insulin^20M post dose glucose ACnc Ser/Plas Pt Qn     ACTIVE Insulin [Units/volume] in Serum or Plasma --20 minutes post dose glucose   MIN DefinitionDescription     mIU/mL;uIU/mL             CHAL   47661-4         Both       0 Insulin 20M p Glc SerPl-aCnc       N   20M p Glc; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; NPH; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente 2.7 2.21               u[IU]/mL       0
47662-2 Insulin^3H post dose glucose ACnc Ser/Plas Pt Qn     ACTIVE Insulin [Units/volume] in Serum or Plasma --3 hours post dose glucose   MIN DefinitionDescription     mIU/mL;uIU/mL             CHAL   47662-2         Both       0 Insulin 3h p Glc SerPl-aCnc       N   3h p Glc; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; NPH; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente 2.73 2.21               u[IU]/mL       0
47663-0 Insulin^30M post dose glucose ACnc Ser/Plas Pt Qn     ACTIVE Insulin [Units/volume] in Serum or Plasma --30 minutes post dose glucose   MIN DefinitionDescription     mIU/mL;uIU/mL             CHAL   47663-0         Both       0 Insulin 30M p Glc SerPl-aCnc       N   30M p Glc; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; NPH; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente 2.73 2.21               u[IU]/mL       0
47664-8 Insulin^3M post dose glucose ACnc Ser/Plas Pt Qn     ACTIVE Insulin [Units/volume] in Serum or Plasma --3 minutes post dose glucose   MIN DefinitionDescription     mIU/mL;uIU/mL             CHAL   47664-8         Both       0 Insulin 3M p Glc SerPl-aCnc       N   3M p Glc; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; NPH; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente 2.7 2.21               u[IU]/mL       0
47665-5 Insulin^5M post dose glucose ACnc Ser/Plas Pt Qn     ACTIVE Insulin [Units/volume] in Serum or Plasma --5 minutes post dose glucose   MIN DefinitionDescription     mIU/mL;uIU/mL             CHAL   47665-5         Both       0 Insulin 5M p Glc SerPl-aCnc       N   5M p dose; 5M p Glc; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; NPH; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente 2.7 2.21               u[IU]/mL       0
47666-3 Insulin^5M pre dose glucose ACnc Ser/Plas Pt Qn     ACTIVE Insulin [Units/volume] in Serum or Plasma --5 minutes pre dose glucose   MIN DefinitionDescription     mIU/mL;uIU/mL             CHAL   47666-3         Both       0 Insulin 5M pre Glc SerPl-aCnc       N   5M pre Glc; Arbitrary Concentration; Before; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; NPH; Pl; Plasma; Plsm; Point in time; pre Glc; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente 2.7 2.21               u[IU]/mL       0
47667-1 Insulin^6M post dose glucagon ACnc Ser/Plas Pt Qn     ACTIVE Insulin [Units/volume] in Serum or Plasma --6 minutes post dose glucagon   MIN DefinitionDescription     mIU/mL;uIU/mL             CHAL   47667-1         Both       0 Insulin 6M p Gc SerPl-aCnc       N   6M p Gc; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; HGF; HUM; Humulin; Hyperglycemic factor; IH7; Insul; Lente; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente 2.7 2.21               u[IU]/mL       0
47668-9 Insulin^pre dose glucose ACnc Ser/Plas Pt Qn     ACTIVE Insulin [Units/volume] in Serum or Plasma --pre dose glucose   MIN DefinitionDescription     mIU/mL;uIU/mL             CHAL   47668-9         Both       0 Insulin pre Glc SerPl-aCnc       N   Arbitrary concentration; Before; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; NPH; Pl; Plasma; Plsm; Point in time; pre Glc; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente 2.73 2.21               u[IU]/mL       0
47669-7 Insulin^pre dose glucagon ACnc Ser/Plas Pt Qn     ACTIVE Insulin [Units/volume] in Serum or Plasma --pre dose glucagon   MIN DefinitionDescription     mIU/mL;uIU/mL             CHAL   47669-7         Both       0 Insulin pre Gc SerPl-aCnc       N   Arbitrary concentration; Before; CHEMISTRY.CHALLENGE TESTING; HGF; HUM; Humulin; Hyperglycemic factor; IH7; Insul; Lente; NPH; Pl; Plasma; Plsm; Point in time; pre Gc; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente 2.7 2.21               u[IU]/mL       0
4767-0 HLA-B56(22) PrThr Bld/Tiss Pt Ord     ACTIVE HLA-B56(22) [Presence]   MIN DefinitionDescription                   HLA   4767-0         Observation       0 HLA-B56(22) Ql           Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue 2.56 1                     This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
47670-5 Insulin^pre-meal ACnc Ser/Plas Pt Qn     ACTIVE Insulin [Units/volume] in Serum or Plasma --pre-meal   MIN DefinitionDescription     mIU/mL;uIU/mL             CHAL   47670-5         Both       0 Insulin pre-meal SerPl-aCnc       N   Arbitrary concentration; Before; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; NPH; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente 2.7 2.21               u[IU]/mL       0
47671-3 Isoleucine SCnc Bld.dot Pt Qn     ACTIVE Isoleucine [Moles/volume] in DBS   MIN DefinitionDescription     umol/L             CHEM   47671-3         Both       0 Isoleucine DBS-sCnc       N   Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Ile; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood 2.7 2.21               umol/L       0
104,672 results found